The promotion of olanzapine in primary care: An examination of internal industry documents
10 juni 2009
Media reports have discussed how olanzapine was marketed off-label for dementia, subsyndromal bipolar disorder, and dementia. Much of this marketing occurred in primary care settings. However, these reports have provided few details.
Bron: Social Science & Medicine (registratie verplicht)
| < Vorige | Volgende > |
|---|
